MedTech Convention

Discover the newest innovations in the MedTech-sector, and see what the future of healthcare will bring!

Sign up here!Pre-register nowRegistrations WILL OPEN SOON
location_on
Universiteitshallen Leuven
calendar_today
November 12, 2025
schedule
19:00

Get inspired at our MedTech Convention 2025!

Our goal: giving students the chance to connect with the most innovative healthtech companies, and learn more about how healthcare is evolving in Belgium.

What to expect?

The MedTech Convention is meant to inform and inspire all students interested in the fascinating world of medical technology. First, some key figures in the MedTech sector in Belgium will give a keynote about their innovative medical technologies, and how they are shaping the future of healthcare.

Afterwards, you get to connect and ask questions to fast-growing, innovative companies all working on various topics within medical technology. Our booth fair allows companies to showcase what they are working on, and how they see healthcare evolving.

Are you a medicine student who wants to know more about what you'll be working with in the future, are you a tech-enthusiast who can't wait to innovate healthcare, or are you simply interested in how you will experience healthcare in the future? The MedTech Convention is the place to be!

Want to join the event?

You can use this pop-up or use the button above to register.

From idea to startup: your journey starts here.

Are you a student or PhD candidate with a bold idea you’d like to turn into a real startup? Sign up now for a wildcard spot and get the chance to pitch in front of VCs and accelerators during our competition.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Ready to be inspired?

Speakers

Our speaker lineup is coming soon!
Geert Meyfroidt
Intensive Care Medicine, UZ Leuven
X
Geert Meyfroidt
Intensive Care Medicine, UZ Leuven

Prof. Dr. Geert Meyfroidt heads the Department of Intensive Care Medicine at UZLeuven and is a professor at KU Leuven. His work bridges clinical practice and data-driven research in critical illness, neuro-intensive care and patient monitoring. He has published widely on brain injury, intracranial pressure and predictive analytics in intensive care. He holds both a medical degree and a PhD from KU Leuven.

Hanne Callewaert
CEO & co-Founder AstriVax Therapeutics
X
Hanne Callewaert
CEO & co-Founder AstriVax Therapeutics

Dr. Hanne Callewaert leads AstriVax Therapeutics, a Belgian biotech developing next-generation vaccines and immunotherapies. She previously worked in R&D and vaccine development at GSK Vaccines and served as chief operating officer at Oxurion. With over 15 years of industry experience, she combines scientific insight with entrepreneurial drive. She holds a PhD in Medical Sciences and a master’s in Biomedical Sciences from KU Leuven, as well as a master’s in Intellectual Property Law.

Herman Verrelst
Founding Partner, Heran Partners
X
Herman Verrelst
Founding Partner, Heran Partners

Herman Verrelst is a founding partner at Heran Partners, supporting early-stage healthtech and biotech ventures. He has over 25 years of leadership experience in diagnostics and technology-driven healthcare. Previously, he founded Cartagenia (acquired by Agilent), served as CEO of Biocartis, and was VP & General Manager at Agilent in California. He holds a master’s degree in Engineering from KU Leuven.

Patrik De Haes
ex-CEO, flanders.bio
X
Patrik De Haes
ex-CEO, flanders.bio

Dr. Patrik De Haes most recently served as CEO of flanders.bio, where he strengthened the region’s life-sciences and medtech ecosystem. Before that, he was CEO of ThromboGenics and led the Global Insulin Infusion Business at Roche Diagnostics. He brings over two decades of international leadership in biotech and medtech innovation. He holds a medical degree from KU Leuven and an MBA from the University of St. Thomas (Minneapolis).

Ready to make an impact?

Booths

Sentigrate
X
Sentigrate

Sentigrate specializes in processing, modeling, andvisualizing complex sensor data, integrating multi-parameter inputs with machine learning foractionable insights. Our focus spans sectors withhealthcare at the forefront, collaborating withclients like KU Leuven to understand diversemedical data. In EEG, we’ve developed epilepsy andParkinson’s management tools, including absenceseizure detection (Epihunter) and Freeze of Gaitprediction. Using PPG, we aid sleep apneadetection via wearable devices (Sunrise), and ouradvanced image analysis supports neuropsychiatricdiagnosis with MRI, PET, and NPE data for KULeuven and UZ Leuven. Our flexible, data-drivensolutions employ signal processing and deeplearning, delivering insights through customdashboards for timely, informed decisions.Sentigrate empowers healthcare providers withprecise, impactful insights.

Website
Revision
X
Revision

ReVision is a startup based on years of
neurotechnology research. We are developing
Occular, the first brain implant that can restore
functional vision to blind individuals. Occular
represents a true breakthrough for the 18 million
people worldwide suffering from nearly all forms of
incurable blindness. Our goal is to create a market
comparable to that of cochlear implants, a sector
currently worth around 2 billion dollars annually.

At present, we have a proof of concept in rhesus
monkeys, demonstrating both the functionality
and the long-term stability and biocompatibility of
the implant. In addition, we have human data from
experiments with a limited number of implanted
electrodes that support our findings.   We are now
raising Series A funding to further develop the
product and begin human trials.

Website
Ooho
X
Ooho

Ooho is a life sciences marketing agency helping biotech, medtech, and service providers bring innovations to market faster through branding, content, and lead generation. With in-house scientists, digital marketers, and creatives, we operate as an extension of your team: low-touch, high-output. Trusted by over 70 clients globally. Ooho has a strong presence across Europe and North America.

Website
OneBonsAI
X
OneBonsAI

OneBonsai proud to present its newest product -
the digital patient.

An Immersive Virtual Training for Future
Healthcare Professionals.

What is the Digital Patient? The Digital Patient is
an interactive virtual simulation of a real person. It’s
built using a mix of real medical data like scans, lab
results, and patient history, and is powered by
advanced AI.

This tool lets students and healthcare professionals
practice taking patient histories, asking the right
questions, and making accurate diagnoses in a
safe, repeatable environment. It’s a modern,
effective way to bring clinical training to life.

Website
Lileo
X
Lileo

Lileo helps mothers pursue breastfeeding inthe best possible conditions with a mobileapp-based service and a Belgian, hospital-grade, wearable connected breast pump.

Website
Fluent
X
Fluent

Fluent Medical is a forthcoming spin-off from KULeuven dedicated to transforming endovascular carethrough robotics. Our mission is to make interventionalworkflows fluent, efficient, and safe, saving crucial timeand improving patient outcomes in stroke treatmentand beyond. By digitizing interventions throughadvanced robotic technologies, we aim to enhanceclinical precision, improve ergonomics, and eliminateradiation exposure for healthcare teams. FluentMedical’s approach opens the door to true remoteinterventions, allowing expert clinicians to treatpatients from thousands of kilometers away, expandingaccess to life-saving procedures globally. Built onstrong academic, clinical, and industrial foundations inEurope, Fluent Medical is driving the future of roboticneuro-intervention and democratizing advanced strokecare worldwide.

Website
Idevax
X
Idevax

Idevax is a medical device company based in Antwerp, specialising in innovative drug delivery solutions for prophylactic and therapeutic applications. Our flagship product, VAX-ID®, is a CE-marked device suited for reliable, standardized, and user-independent intradermal delivery with minimal training and high degree of ease of use.

VAX-ID® is designed to support a broad spectrum of applications, including cell and gene therapies, immunotherapies such as cancer vaccines, pandemic preparedness, and vaccine shortages or high costs. With its unique ability to consistently deliver into the dermis, it offers important advantages such as enhancing immune response, supporting patient compliance, with the potential to transform therapy accessibility.

Website
Cryotherapeutics
X
Cryotherapeutics

CryoTherapeutics is an early-stage European innovator developing a system for use by interventional cardiologists to treat atherosclerotic plaque that causes heart attacks by delivering cryo-energy to the coronary arteries.

Website
Covartim
X
Covartim

At COVARTIM we help healthcare practitioners,
SMEs and startups develop Medical Devices and In-
Vitro Diagnostic Devices. We support our clients
from the early stages of their product development
to the introduction on the market.

Our experts are ready to step into a project at
every step of the process: R&D, Prototyping &
Manufacturing, Verification, Validation, Quality
Assurance, Regulatory Assurance, QMS.

We are passionate about medtech. We are
proud to be part of the challenging and thriving
Belgian ecosystem and to contribute to the
growth of the Belgian industry.

Website
Comunicare
X
Comunicare

Comunicare Solutions develops and commercialises a digital multipathology solution to support patients in chronic care and post-hospitalisation contexts. The Comunicare telemedicine platform provides, through patient empowerment, remote monitoring, and disease-specific predictive models, a non-pharmacological strategy to improve disease management at home. It also provides support for patient data collection in clinical trials, is already reimbursed in Belgium and France for specific care pathways.

Website
Axabio
X
Axabio

At axabio®, an Antwerp-based biotech startup, wehelp nutraceutical & cosmetic brands bringwinning products to market with the nextgeneration of natural astaxanthin. We harness thepower of microalgae to create one of the mostvaluable ingredients on the planet in our patentedphotobioreactor, the perfect blend between natureand technology. We go beyond being a rawmaterial supplier by offering formulation expertise,scientific support, and co-marketing, so brands canaccelerate launches and build compellingconsumer stories.

Website
3Dsystems
X
3Dsystems

3D Systems is a key player in the world of AdditiveManufacturing (3D Printing), with a strong focus onhealthcare solutions. The Leuven office, also known asLayerWise, started as a spinoff from the KU LeuvenDepartment of Mechanical Engineering in 2008,before being acquired in 2014. Today, our Leuvenoffice employs over 200 people who collaborate withinternational partners to design, develop, andproduce reliable, high-quality medical devices. Over100,000 implants are shipped each year from ourfacility to distributors and operating roomsworldwide, and our team of engineers is working oninnovative solutions that will shape the future ofmedical applications.

Website

What will the event look like?

Timeline

Will be announced soon!

19:00 Doors open

19:30 Welcome by NEXT

19:40 Introduction by Siemens Healthineers

19:50 Speaker 1: Hanne Callewaert

20:05 Speaker 2: Geert Meyfroidt

20:20 Panel Discussion

20:50 Booth Fair

23:00 The End

Need some convincing?

Aftermovie

Thanks to our Partners!

No items found.

Thanks to our organiser(s)

Want to help organise the next edition? Apply here

Eloïse Jansen
Vincent Jacobs
full team